TY - JOUR
T1 - Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase
AU - Sonne-Schmidt, Carsten Scavenius
AU - Sanggaard, Kristian Wejse
AU - Nikolajsen, Camilla Lund
AU - Bak, Steffen
AU - Valnickova, Zuzana
AU - Thøgersen, Ida
AU - Jensen, Ole N
AU - Højrup, Peter
AU - Enghild, Jan J.
N1 - Copyright © 2011. Published by Elsevier B.V.
PY - 2011
Y1 - 2011
N2 - In this study, we show that inter-α-inhibitor is a substrate for both factor XIIIa and tissue transglutaminase. These enzymes catalyze the incorporation of dansylcadaverine and biotin-pentylamine, revealing that inter-α-inhibitor contains reactive Gln residues within all three subunits. These findings suggest that transglutaminases catalyze the covalent conjugation of inter-α-inhibitor to other proteins. This was demonstrated by the cross-linking between inter-α-inhibitor and fibrinogen by either factor XIIIa or tissue transglutaminase. Finally, using quantitative mass spectrometry, we show that inter-α-inhibitor is cross-linked to the fibrin clot in a 1:20 ratio relative to the known factor XIIIa substrate α2-antiplasmin. This interaction may protect fibrin or other Lys-donating proteins from adventitious proteolysis by increasing the local concentration of bikunin. In addition, the reaction may influence the TSG-6/heavy Chain 2-mediated transfer of heavy chains observed during inflammation.
AB - In this study, we show that inter-α-inhibitor is a substrate for both factor XIIIa and tissue transglutaminase. These enzymes catalyze the incorporation of dansylcadaverine and biotin-pentylamine, revealing that inter-α-inhibitor contains reactive Gln residues within all three subunits. These findings suggest that transglutaminases catalyze the covalent conjugation of inter-α-inhibitor to other proteins. This was demonstrated by the cross-linking between inter-α-inhibitor and fibrinogen by either factor XIIIa or tissue transglutaminase. Finally, using quantitative mass spectrometry, we show that inter-α-inhibitor is cross-linked to the fibrin clot in a 1:20 ratio relative to the known factor XIIIa substrate α2-antiplasmin. This interaction may protect fibrin or other Lys-donating proteins from adventitious proteolysis by increasing the local concentration of bikunin. In addition, the reaction may influence the TSG-6/heavy Chain 2-mediated transfer of heavy chains observed during inflammation.
U2 - 10.1016/j.bbapap.2011.08.017
DO - 10.1016/j.bbapap.2011.08.017
M3 - Journal article
C2 - 21939789
VL - 1814
SP - 1624
EP - 1630
JO - BBA General Subjects
JF - BBA General Subjects
SN - 0304-4165
IS - 12
ER -